Clinical features of LRRK2-associated Parkinson's disease in central Norway
- PMID: 15852371
- DOI: 10.1002/ana.20456
Clinical features of LRRK2-associated Parkinson's disease in central Norway
Abstract
Several pathogenic mutations in the leucine-rich repeat kinase 2 (LRRK2; PARK8) gene recently have been identified in familial and sporadic parkinsonism. We screened 435 Norwegian patients diagnosed with Parkinson's disease and 519 control subjects for the presence of 7 LRRK2 mutations. Nine patients from seven families were found to be heterozygote carriers of the LRRK2 6055G>A (G2019S) mutation. Twelve of 28 first-degree relatives also carried the mutation, but only 1 had Parkinson's disease. The clinical features included asymmetric resting tremor, bradykinesia, and rigidity with a good response to levodopa and could not be distinguished from idiopathic Parkinson's disease.
Similar articles
-
A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.Eur J Neurol. 2007 Apr;14(4):413-7. doi: 10.1111/j.1468-1331.2007.01685.x. Eur J Neurol. 2007. PMID: 17388990
-
[Clinical features of LRRK2-associated Parkinson's disease].Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(12):56-62. Zh Nevrol Psikhiatr Im S S Korsakova. 2011. PMID: 22433811 Russian.
-
LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease.Neurosci Lett. 2006 Mar 13;395(3):224-6. doi: 10.1016/j.neulet.2005.10.083. Epub 2005 Nov 18. Neurosci Lett. 2006. PMID: 16298482
-
[Clinical molecular genetics for PARK8 (LRRK2)].Brain Nerve. 2007 Aug;59(8):839-50. Brain Nerve. 2007. PMID: 17713120 Review. Japanese.
-
LRRK2 in Parkinson's disease: genetic and clinical studies from patients.FEBS J. 2009 Nov;276(22):6455-63. doi: 10.1111/j.1742-4658.2009.07344.x. Epub 2009 Oct 5. FEBS J. 2009. PMID: 19804413 Review.
Cited by
-
Iroquois Homeobox Protein 2 Identified as a Potential Biomarker for Parkinson's Disease.Int J Mol Sci. 2020 May 14;21(10):3455. doi: 10.3390/ijms21103455. Int J Mol Sci. 2020. PMID: 32422864 Free PMC article.
-
LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool.J Neurosci. 2011 Feb 9;31(6):2225-37. doi: 10.1523/JNEUROSCI.3730-10.2011. J Neurosci. 2011. PMID: 21307259 Free PMC article.
-
Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease.Sci Transl Med. 2012 Jul 4;4(141):141ra90. doi: 10.1126/scitranslmed.3003985. Sci Transl Med. 2012. PMID: 22764206 Free PMC article.
-
Metabolomic profiling in LRRK2-related Parkinson's disease.PLoS One. 2009 Oct 22;4(10):e7551. doi: 10.1371/journal.pone.0007551. PLoS One. 2009. PMID: 19847307 Free PMC article.
-
PINK1 mutation heterozygosity and the risk of Parkinson's disease.J Neurol Neurosurg Psychiatry. 2007 Jan;78(1):82-4. doi: 10.1136/jnnp.2006.097840. J Neurol Neurosurg Psychiatry. 2007. PMID: 17172567 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases